MedPath

Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery

Phase 1
Completed
Conditions
Anterior Cruciate Ligament Reconstruction
Interventions
Device: Neuromuscular electrical stimulation
Device: Microstimulation
Registration Number
NCT02945553
Lead Sponsor
University of Vermont
Brief Summary

Traumatic knee injury is common and highly debilitating. Surgical reconstruction/repair improves knee biomechanics and function, but neuromuscular dysfunction persist for years despite rehabilitation, hindering resumption of normal activities, increasing risk of further injury and, in a majority of patients, hastening the development of knee osteoarthritis (OA). Our goal in this research study is to evaluate the utility of neuromuscular electrical stimulation (NMES), initiated following injury and maintained through the early post-surgical period, to prevent muscle atrophy and intrinsic contractile dysfunction compared to active control intervention of micro-electrical stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • 18-50 yrs
  • BMI <35 kg/m2
  • acute, first-time, ACL rupture with or without meniscus injury
  • scheduled to undergo reconstruction with a BPTB autograft
Read More
Exclusion Criteria
  • history of prior knee/lower extremity surgery or non-surgical intervention (eg, intra-articular injection) on either leg
  • abnormal laxity of any lower extremity ligament other than the injured ACL
  • signs or symptoms of arthritis, autoimmune or inflammatory disease or diabetes
  • grade IIIb or greater articular cartilage lesions (ICRS criteria)
  • women who are/plan on becoming pregnant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NMESNeuromuscular electrical stimulationNeuromuscular electrical stimulation (NMES) group
MicrostimulationMicrostimulationMicrostimulation
Primary Outcome Measures
NameTimeMethod
Cross-sectional Area of Skeletal Muscle Fibers (All Fibers)Difference between injured and non-injured leg at 3 weeks post-surgery

Cross-sectional area of skeletal muscle fibers will be evaluated using immunohistochemistry, with specification of all relevant muscle fiber types

Maximal Single Muscle Fiber Shortening Velocity (Myosin Heavy Chain (MHC) IIA Fibers)Difference between injured and non-injured leg at 3 weeks post-surgery

Maximal shortening velocity from segments of chemically-skinned single human muscle fibers will be assessed, with muscle fiber type determined post-measurement by gel electrophoresis

Cross-sectional Area of Skeletal Muscle Fibers (MHC IIA)Difference between injured and non-injured leg at 3 weeks post-surgery

Cross-sectional area of skeletal muscle fibers will be evaluated using immunohistochemistry, with specification of all relevant muscle fiber types

Cross-sectional Area of Skeletal Muscle Fibers (Myosin Heavy Chain (MHC) I Fibers)Difference between injured and non-injured leg at 3 weeks post-surgery

Cross-sectional area of skeletal muscle fibers will be evaluated using immunohistochemistry, with specification of all relevant muscle fiber types

Maximal Calcium-activated Tension Single Muscle Fiber Tension (Myosin Heavy Chain (MHC) IIA Fibers)Difference between injured and non-injured leg at 3 weeks post-surgery

Tension (force per unit muscle fiber cross-sectional area) from segments of chemically-skinned single human muscle fibers will be assessed under maximal calcium-activated condition, with muscle fiber type determined post-measurement by gel electrophoresis

Secondary Outcome Measures
NameTimeMethod
Knee Extensor Peak Isokinetic TorqueDifference between injured and non-injured leg at 6 months post-surgery

Peak isokinetic torque is measures in injured and non-injurd leg at 60 deg/s using dynamometry

Trial Locations

Locations (1)

University of Vermont College of Medicine

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath